TG Therapeutics | TGTX - Deudores Comerciales

Precio De Mercado
30.16
Cambio Diario
-0.29 -0.95%
Mensual
1.69%
Anual
-29.53%
Q1 Expectativa
29.17




Deudores Comerciales Cambio Fecha
AbbVie USD 12.77B 132M 2025-09
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.57B 1.08B 2025-12
Ardelyx USD 71.85M 4.76M 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Bayer EUR 14.19B 720M 2025-12
Biogen USD 1.85B 234M 2025-09
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Curis USD 2.55M 400K 2024-06
Gilead Sciences USD 4.91B 182M 2025-12
J&J USD 17.61B 235M 2025-09
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Novartis USD 12.29B 3.3B 2025-12
Novavax USD 106.45M 72.27M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
TG Therapeutics USD 265.38M 33.86M 2025-09
Verastem USD 200K 10.72M 2024-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12